MADISON,
Wis., Jan. 22, 2025 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) will report financial results for the
second quarter of fiscal year 2025, ended December 31, 2024, during a conference call
hosted by company management at 1:30 p.m.
PT/4:30 p.m. ET on
February 5, 2025.
The conference call dial-in numbers are (833)
316-0563 (USA) or (412) 317-5747
(international). In addition, a dial-up replay of the conference
call will be available approximately one hour after the call's
conclusion for one week. The replay number is 1-877-344-7529
(USA) or 1-412-317-0088
(international), conference ID: 8496951.
A live webcast of the call will also be available
from the Investor Relations section of the company's website at
investors.accuray.com. A webcast replay can be accessed on the
website and will remain available until Accuray announces its
results for the third quarter of fiscal 2025.
About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding the
powerful potential of radiation therapy to improve as many lives as
possible. We invent unique, market-changing solutions that are
designed to deliver radiation treatments for even the most complex
cases—while making commonly treatable cases even easier—to meet the
full spectrum of patient needs. We are dedicated to continuous
innovation in radiation therapy for oncology, neuro-radiosurgery,
and beyond, as we partner with clinicians and administrators,
empowering them to help patients get back to their lives, faster.
Accuray is headquartered in Madison,
Wisconsin, with facilities worldwide. To learn more, visit
www.accuray.com or follow us on Facebook, LinkedIn, X, and
YouTube.
Investor Contact
Aman Patel, CFA
Investor Relations, ICR Healthcare
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-second-quarter-fiscal-2025-financial-results-on-february-5-2025-302357164.html
SOURCE Accuray Incorporated